Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

Max Bayer

Pharma Reporter

With the Trump administration’s planned pharma tariffs on the horizon, Pfizer CEO Albert Bourla gave an optimistic read on Tuesday when asked how he thought …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts

Pfizer launches a new wave of cost cuts, expects $7.7B in total savings through 2027

FDA won't reorganize medical product centers, Makary says in interview: 'I rejected that proposal'

FDA approves Abeona’s skin disease cell therapy

Artios drug exploits ‘replication stress’ in cancer, shrinking subset of tumors in early study

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Pharma Reporter

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies